Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Segment Information (Tables)

v3.8.0.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Summary of Segment Information

The following table summarizes segment information for the years ended December 31, 2017, 2016 and 2015 (in thousands).  

 

 

 

For the Years Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Net revenues:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical testing

 

$

231,748

 

 

$

222,015

 

 

$

98,595

 

Pharma Services

 

 

26,863

 

 

 

22,068

 

 

 

1,207

 

Total Revenue

 

$

258,611

 

 

$

244,083

 

 

$

99,802

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical testing

 

$

121,785

 

 

$

120,437

 

 

$

55,802

 

Pharma Services

 

 

16,510

 

 

 

13,267

 

 

 

244

 

Total Cost of Revenue

 

$

138,295

 

 

$

133,704

 

 

$

56,046

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin:

 

 

 

 

 

 

 

 

 

 

 

 

Clinical testing

 

$

109,963

 

 

$

101,578

 

 

$

42,793

 

Pharma Services

 

 

10,353

 

 

 

8,801

 

 

 

963

 

Total Gross Margin

 

$

120,316

 

 

$

110,379

 

 

$

43,756